SCHEMBL3484950

SCHEMBL3484950

NS(=O)(=O)c1ccc(NC(=O)CCCOc2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.68
LMNA P02545 3/20 0.68
ALDH1A1 P00352 1/20 0.68
MEN1 O00255 9/20 0.62
KMT2A Q03164 9/20 0.62
MAPT P10636 4/20 0.62
POLB P06746 4/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
GAA P10253 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.58
TSHR P16473 1/20 0.57
PKM P14618 1/20 0.56
KDM4E B2RXH2 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
RAB9A P51151 2/20 0.56
NLRP1 Q9C000 1/20 0.56
NPC1 O15118 1/20 0.55
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1091470 0.90 HPGD (0.73) HPGDLMNAALDH1A1MEN1KMT2A
SCHEMBL3279205 0.86 HPGD (0.74) HPGDLMNAALDH1A1MEN1KMT2A
SCHEMBL10165449 0.84 MEN1 (0.65) HPGDLMNAALDH1A1MEN1KMT2A
SCHEMBL3279199 0.84 HPGD (0.71) HPGDLMNAALDH1A1MEN1KMT2A
SCHEMBL12534318 0.83 HPGD (0.74) HPGDLMNAALDH1A1MEN1KMT2A
SCHEMBL1090261 0.83 HPGD (0.77) HPGDLMNAALDH1A1MEN1KMT2A
SCHEMBL9974126 0.81 HPGD (0.56) HPGDLMNAALDH1A1MEN1KMT2A
SCHEMBL8388592 0.79 MEN1 (0.67) HPGDLMNAALDH1A1MEN1KMT2A
SCHEMBL1090961 0.79 MEN1 (0.64) HPGDLMNAALDH1A1MEN1KMT2A
SCHEMBL8391577 0.79 HPGD (0.56) HPGDLMNAALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263642-B2 Antimicrobial compounds and methods of use thereof VANDERBILT UNIVERSITY (US) 2012-09-11 US disclosed
US-8263642-B2 Antimicrobial compounds and methods of use thereof VANDERBILT UNIVERSITY (US) 2012-09-11 US disclosed
US-20100004324-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF VANDERBILT UNIVERSITY 2010-01-07 US disclosed
US-20100004324-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF VANDERBILT UNIVERSITY 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004324-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF HMOX1, HMOX2, NOD2 HPGD 449/4885LMNA 3279/4885ALDH1A1 4316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.